Developing a low-cost platform for producing and testing PET imaging agents
Microchip electrophoresis as basis for fully integrated, fully automated, low-cost radiopharmaceutical QC platform
This study is working on a new, easy-to-use machine that makes and checks special imaging substances called PET tracers, which can help doctors see inside the body better, making it easier and cheaper for patients to get important scans for their health.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dropletpharm INC. NIH-funded |
| Lab location | 1 site (Sherman Oaks, United States) |
| Project ID | NIH-10697506 on NIH RePORTER |
What this research studies
This research focuses on creating a new, automated system for producing and testing PET tracers, which are essential for advanced medical imaging. By utilizing microfluidic technology, the project aims to simplify the production process, reduce costs, and ensure the safety of these tracers through integrated quality control. Patients could benefit from more accessible and affordable PET imaging, which can enhance diagnosis and treatment monitoring. The approach involves developing a compact device that combines both the synthesis of tracers and their quality testing.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients requiring PET imaging for diagnosis or treatment monitoring.
Not a fit: Patients who do not require PET imaging or those with conditions that cannot be assessed using PET will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could make PET imaging more affordable and widely available for patients.
How similar studies have performed: Previous research has shown promise in using microfluidics for tracer production, indicating potential success for this novel approach.
Where this research is happening
Sherman Oaks, United States
- Dropletpharm INC. — Sherman Oaks, United States (Active)
Researchers
- Principal investigator: Jones, Jason — Dropletpharm INC.
- Study coordinator: Jones, Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.